Applications for this meeting must be submitted by May 20, 2017. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the Conference Chair if more seats become available due to cancellations.
GRS Speaker Abstract Deadline: Although applications will be accepted until the date noted above, any applicants who wish to be considered for an oral presentation should submit their application by April 7, 2017. Please refer to the application instructions in the Meeting Description section below for more details (if available).
The Gordon Research Seminar on Atherosclerosis is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.
overarching goal is to provide a forum for leading and emerging scientists to
interact informally, discuss the latest discoveries and ideas, and to provide
an overview of current research themes in the atherosclerosis field. We aim to provide a
platform for young investigators to interact and represent their latest
research in a peer-to-peer environment that also includes for the first time
career training elements. We expect discussion about novel data on
atherogenesis pathways, such as endothelial dysfunction, imbalanced lipid
metabolism and clearance, innate immune memory, maladaptive immune responses
and the interplay between inflammation and plaque complication.
The meeting will feature approximately 10 talks and 2 poster sessions. All attendees are expected to actively participate in the GRS either by giving an oral presentation or presenting a poster. Therefore, all applications must include an abstract.
The Chairs will select speakers from abstracts submitted by April 7, 2017. Those applicants who are not chosen for talks and those who apply after the deadline to be considered for an oral presentation will be expected to present a poster. In order to participate, you must submit an application by the date indicated in the Application Deadline section above.
This GRS will be held in conjunction with the "Atherosclerosis" Gordon Research Conference (GRC)
. Those interested in attending both meetings must submit an application for the GRC in addition to an application for the GRS. Refer to the associated GRC program page
for more information.
|2:00 pm - 5:00 pm||Arrival and Check-in|
|3:30 pm - 3:45 pm||Introductory Comments by GRC Site Staff / Welcome by the GRS Conference Chair|
|3:45 pm - 4:30 pm||Keynote Session: Wanted Dead or Alive: Inflammatory Macrophages in Vascular Disease|
|Discussion Leader: Sylvia Nuernberg (University of Pennsylvania, USA)|
|3:45 pm - 4:25 pm||Katey Rayner (University of Ottawa Heart Institute, Canada)|
"Wanted Dead or Alive: Inflammatory Macrophages in Vascular Disease"
|4:25 pm - 4:30 pm||Discussion|
|4:30 pm - 6:00 pm||Poster Session|
|7:30 pm - 9:30 pm||Lipids, Macrophages and Inflammation|
|Discussion Leader: Holger Winkels (La Jolla Institute for Allergy and Immunology, USA)|
|7:30 pm - 7:45 pm||Bastian Ramms (University of California, San Diego, USA)|
"Apolipoprotein E Determines the Functional and Atherosclerotic Fate of Apolipoprotein C-III"
|7:45 pm - 7:50 pm||Discussion|
|7:50 pm - 8:05 pm||C Scipione (Robarts Research Institute, Canada)|
"Characterization of the Pro-Inflammatory Oxidized Phosphocholine Adduct on Lipoprotein(a)"
|8:05 pm - 8:10 pm||Discussion|
|8:10 pm - 8:25 pm||Ada Weinstock (New York University School of Medicine, USA)|
"Novel Regulation of Macrophage Polarization and Atherosclerosis Regression by Wnt"
|8:25 pm - 8:30 pm||Discussion|
|8:30 pm - 8:45 pm||Mandy van Leent (Icahn School of Medicine at Mount Sinai, USA)|
"Targeted CD40-TRAF6 Inhibition Resolves Macrophage Accumulation in Atherosclerosis"
|8:45 pm - 8:50 pm||Discussion|
|8:50 pm - 9:05 pm||Shuang Zhang (Northwestern University, USA)|
"Mitochondrial-Directed Macrophage Reprogramming During Efferocytosis and Post Myocardial Infarction"
|9:05 pm - 9:10 pm||Discussion|
|9:10 pm - 9:25 pm||Cameron McAlpine (Massachusetts General Hospital, USA)|
"Sleep Restricts Hematopoiesis and Protects Against Atherosclerosis"
|9:25 pm - 9:30 pm||Discussion|
|7:30 am - 8:30 am||Breakfast|
|9:00 am - 11:00 am||Novel Paradigms for Atherosclerosis Drug Discovery|
|Discussion Leader: Isabel Schellinger (Heart Research Center Göttingen, Germany)|
|9:00 am - 9:15 am||Richard Bayliss (University of Virginia, USA)|
"SMC Appear to be the Primary Cell Type Responding to IL1β Within Atherosclerotic Lesions"
|9:15 am - 9:20 am||Discussion|
|9:20 am - 9:35 am||Eva Kritikou (Leiden Academic Centre for Drug Research (LACDR), Leiden University, The Netherlands)|
"Hypercholesterolemia Induces a Mast Cell-CD4+ T-Cell Interaction in Atherosclerosis"
|9:35 am - 9:40 am||Discussion|
|9:40 am - 9:55 am||Annelie Shami (Academic Medical Center, University of Amsterdam, The Netherlands)|
"GITR Activation Promotes Regulatory CD4+ T-Cell Responses and Stimulates Leukocyte Recruitment in Atherosclerotic Plaques"
|9:55 am - 10:00 am||Discussion|
|10:00 am - 10:15 am||Max Senders (Icahn School of Medicine at Mount Sinai, USA)|
"Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Experimental Atherosclerosis"
|10:15 am - 10:20 am||Discussion|
|10:20 am - 10:35 am||Vikram Shende (California Institute for Biomedical Research, USA)|
"Identification of Small Molecule Suppressors of PCSK9 for the Treatment of Hypercholesterolemia"
|10:35 am - 10:40 am||Discussion|
|10:40 am - 10:55 am||Rhogerry Deshycka (Whitehead Institute for Biomedical Research, USA)|
"Engineered Red Blood Cells Carrying PCSK9 Inhibitors as Cholesterol Blockbuster"
|10:55 am - 11:00 am||Discussion|
|11:00 am - 12:30 pm||Poster Session|
|Coffee will be served in the poster area from 11:00 am - 11:30 am|
|1:30 pm - 2:30 pm||Mentorship Component: Taking the Next Step in Your Research Career|
|Discussion Leader: Andrew Sage (University of Cambridge, United Kingdom)|
|1:30 pm - 1:50 pm||Michelle Olive (National Heart, Lung, and Blood Institute, NIH, USA)|
"Sourcing Support for Your Research"
|1:50 pm - 2:00 pm||Discussion|
|2:00 pm - 2:20 pm||Lauren Celano (Propel Careers, USA)|
"Smooth Transitions – Moving to a Career Outside of Academia"
|2:20 pm - 2:30 pm||Discussion|
|2:30 pm - 3:00 pm||Evaluation Period|
|Fill in GRS Evaluation Forms|
|3:00 pm||Seminar Concludes|
Funding for this conference was made possible (in part) by 1R13HL137211-01 from the National Heart, Lung and Blood Institute.The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.